Zentalis Pharmaceuticals, Inc.
$333.92M- Market cap
- $285.25M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.95x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.23x
$3.98Latest market snapshot
Implied fair value · at AIV's multiple
$2.4737.9% below market
0.94 ZNTL revenue / share×2.63x AIV P/S=$2.47
Market $3.98Implied $2.47
AIV · current priceP/S 2.63x
$2.53Latest market snapshot
Implied fair value · at ZNTL's multiple
$4.0761.0% above market
0.96 AIV revenue / share×4.23x ZNTL P/S=$4.07
Market $2.53Implied $4.07